Eli Lilly LLY
NYSE LLY
$1,284.64 +44.30 (+3.57%)
As of: Oct 20, 2026 · 3:59 PM EDT

Eli Lilly (LLY) Assets (2009 - 2026)

Updated

Eli Lilly (LLY) recorded Assets of $142.28 billion in Q2 2026, up 41.0% from $100.92 billion a year earlier and up 22.1% from the prior quarter.

Analysis

Eli Lilly (LLY) Assets (2009 - 2026) Analysis & Trends

At the end of FY2025, Eli Lilly reported Assets of $112.48 billion, up 42.9% from FY2024.

  • Annual Assets has increased for six straight years, with a five-year compound annual growth rate of 19.3% (FY2020 to FY2025).
  • Across earlier years, Assets came in at $78.72 billion in FY2024 (+23.0%), $64.01 billion in FY2023 (+29.3%), $49.49 billion in FY2022 (+1.4%) and $48.81 billion in FY2021 (+4.7%).
  • The Q2 2026 figure is the highest quarterly Assets in data going back to Q2 2009.
  • On a year-over-year basis, Assets has increased for 15 consecutive quarters, with growth averaging 37.5% over the last eight quarters.
  • Peak year-over-year performance for Assets in the last five years was growth of 52.0% in Q3 2025, against a decline of 1.6% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $116.58 billion (Q1 2026), $112.48 billion (Q4 2025) and $114.94 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 201.06 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 135.12 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 115.83 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 49.36 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 201.13 Bn
10 Vertex Pharmaceuticals 130.00 Bn 102.01 Bn 2.84 Bn 27.42 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 142.28 Bn
Mar 31, 2026 116.58 Bn
Dec 31, 2025 112.48 Bn
Sep 30, 2025 114.94 Bn
Jun 30, 2025 100.92 Bn
Mar 31, 2025 89.39 Bn
Dec 31, 2024 78.72 Bn
Sep 30, 2024 75.61 Bn
Jun 30, 2024 71.87 Bn
Mar 31, 2024 63.94 Bn
Dec 31, 2023 64.01 Bn
Sep 30, 2023 57.92 Bn
Jun 30, 2023 54.81 Bn
Mar 31, 2023 53.16 Bn
Dec 31, 2022 49.49 Bn
Sep 30, 2022 47.46 Bn
Jun 30, 2022 47.06 Bn
Mar 31, 2022 46.92 Bn
Dec 31, 2021 48.81 Bn
Sep 30, 2021 48.19 Bn
API Access

Eli Lilly Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=LLY&period=max&api_key=YOUR_API_KEY